0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Universal CAR-T Cell Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35Z16381
Home | Market Reports | Health| Nursing
Global Universal CAR T Cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Universal CAR-T Cell Therapy Market Research Report 2025

Code: QYRE-Auto-35Z16381
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Universal CAR-T Cell Therapy Market

The global market for Universal CAR-T Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Off-the-shelf CAR-T cells are CAR-T cells prepared using allogeneic T cells, also known as "off-the-shelf" and universal. Usually, T cells are collected from healthy donors or T cells derived from stem cells are used directly. After HLA matching, a successfully designed CAR (such as CD19 CAR) is loaded onto the surface of the T cells.
North American market for Universal CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Universal CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Universal CAR-T Cell Therapy in Hematoma is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Universal CAR-T Cell Therapy include Cellectis, Allogene, Caribou, Poseida Therapeutics, Bangyao Biotechnology, Usano, Keji Pharmaceutical, Beiheng Biotechnology, Grace Biotechnology, Celyad, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Universal CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Universal CAR-T Cell Therapy.
The Universal CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Universal CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Universal CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Universal CAR-T Cell Therapy Market Report

Report Metric Details
Report Name Universal CAR-T Cell Therapy Market
Segment by Type
  • First Generation CARs
  • Second Generation CARs
  • Third Generation CARs
Segment by Application
  • Hematoma
  • Solid Tumor
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellectis, Allogene, Caribou, Poseida Therapeutics, Bangyao Biotechnology, Usano, Keji Pharmaceutical, Beiheng Biotechnology, Grace Biotechnology, Celyad, CRISPR Therapeutics, Precision BioSciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Universal CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Universal CAR-T Cell Therapy Market report?

Ans: The main players in the Universal CAR-T Cell Therapy Market are Cellectis, Allogene, Caribou, Poseida Therapeutics, Bangyao Biotechnology, Usano, Keji Pharmaceutical, Beiheng Biotechnology, Grace Biotechnology, Celyad, CRISPR Therapeutics, Precision BioSciences

What are the Application segmentation covered in the Universal CAR-T Cell Therapy Market report?

Ans: The Applications covered in the Universal CAR-T Cell Therapy Market report are Hematoma, Solid Tumor

What are the Type segmentation covered in the Universal CAR-T Cell Therapy Market report?

Ans: The Types covered in the Universal CAR-T Cell Therapy Market report are First Generation CARs, Second Generation CARs, Third Generation CARs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Universal CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 First Generation CARs
1.2.3 Second Generation CARs
1.2.4 Third Generation CARs
1.3 Market by Application
1.3.1 Global Universal CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hematoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Universal CAR-T Cell Therapy Market Perspective (2020-2031)
2.2 Global Universal CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global Universal CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Universal CAR-T Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Universal CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Universal CAR-T Cell Therapy Market Dynamics
2.3.1 Universal CAR-T Cell Therapy Industry Trends
2.3.2 Universal CAR-T Cell Therapy Market Drivers
2.3.3 Universal CAR-T Cell Therapy Market Challenges
2.3.4 Universal CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Universal CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top Universal CAR-T Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Universal CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Universal CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Universal CAR-T Cell Therapy Revenue
3.4 Global Universal CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global Universal CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Universal CAR-T Cell Therapy Revenue in 2024
3.5 Global Key Players of Universal CAR-T Cell Therapy Head office and Area Served
3.6 Global Key Players of Universal CAR-T Cell Therapy, Product and Application
3.7 Global Key Players of Universal CAR-T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Universal CAR-T Cell Therapy Breakdown Data by Type
4.1 Global Universal CAR-T Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Universal CAR-T Cell Therapy Breakdown Data by Application
5.1 Global Universal CAR-T Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Universal CAR-T Cell Therapy Market Size (2020-2031)
6.2 North America Universal CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Universal CAR-T Cell Therapy Market Size by Country (2020-2025)
6.4 North America Universal CAR-T Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Universal CAR-T Cell Therapy Market Size (2020-2031)
7.2 Europe Universal CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Universal CAR-T Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Universal CAR-T Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Universal CAR-T Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Universal CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Universal CAR-T Cell Therapy Market Size (2020-2031)
9.2 Latin America Universal CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Universal CAR-T Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Universal CAR-T Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Universal CAR-T Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Universal CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellectis
11.1.1 Cellectis Company Details
11.1.2 Cellectis Business Overview
11.1.3 Cellectis Universal CAR-T Cell Therapy Introduction
11.1.4 Cellectis Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.1.5 Cellectis Recent Development
11.2 Allogene
11.2.1 Allogene Company Details
11.2.2 Allogene Business Overview
11.2.3 Allogene Universal CAR-T Cell Therapy Introduction
11.2.4 Allogene Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.2.5 Allogene Recent Development
11.3 Caribou
11.3.1 Caribou Company Details
11.3.2 Caribou Business Overview
11.3.3 Caribou Universal CAR-T Cell Therapy Introduction
11.3.4 Caribou Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.3.5 Caribou Recent Development
11.4 Poseida Therapeutics
11.4.1 Poseida Therapeutics Company Details
11.4.2 Poseida Therapeutics Business Overview
11.4.3 Poseida Therapeutics Universal CAR-T Cell Therapy Introduction
11.4.4 Poseida Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.4.5 Poseida Therapeutics Recent Development
11.5 Bangyao Biotechnology
11.5.1 Bangyao Biotechnology Company Details
11.5.2 Bangyao Biotechnology Business Overview
11.5.3 Bangyao Biotechnology Universal CAR-T Cell Therapy Introduction
11.5.4 Bangyao Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.5.5 Bangyao Biotechnology Recent Development
11.6 Usano
11.6.1 Usano Company Details
11.6.2 Usano Business Overview
11.6.3 Usano Universal CAR-T Cell Therapy Introduction
11.6.4 Usano Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.6.5 Usano Recent Development
11.7 Keji Pharmaceutical
11.7.1 Keji Pharmaceutical Company Details
11.7.2 Keji Pharmaceutical Business Overview
11.7.3 Keji Pharmaceutical Universal CAR-T Cell Therapy Introduction
11.7.4 Keji Pharmaceutical Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.7.5 Keji Pharmaceutical Recent Development
11.8 Beiheng Biotechnology
11.8.1 Beiheng Biotechnology Company Details
11.8.2 Beiheng Biotechnology Business Overview
11.8.3 Beiheng Biotechnology Universal CAR-T Cell Therapy Introduction
11.8.4 Beiheng Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.8.5 Beiheng Biotechnology Recent Development
11.9 Grace Biotechnology
11.9.1 Grace Biotechnology Company Details
11.9.2 Grace Biotechnology Business Overview
11.9.3 Grace Biotechnology Universal CAR-T Cell Therapy Introduction
11.9.4 Grace Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.9.5 Grace Biotechnology Recent Development
11.10 Celyad
11.10.1 Celyad Company Details
11.10.2 Celyad Business Overview
11.10.3 Celyad Universal CAR-T Cell Therapy Introduction
11.10.4 Celyad Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.10.5 Celyad Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Details
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics Universal CAR-T Cell Therapy Introduction
11.11.4 CRISPR Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.11.5 CRISPR Therapeutics Recent Development
11.12 Precision BioSciences
11.12.1 Precision BioSciences Company Details
11.12.2 Precision BioSciences Business Overview
11.12.3 Precision BioSciences Universal CAR-T Cell Therapy Introduction
11.12.4 Precision BioSciences Revenue in Universal CAR-T Cell Therapy Business (2020-2025)
11.12.5 Precision BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Universal CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of First Generation CARs
 Table 3. Key Players of Second Generation CARs
 Table 4. Key Players of Third Generation CARs
 Table 5. Global Universal CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Universal CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Universal CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Universal CAR-T Cell Therapy Market Share by Region (2020-2025)
 Table 9. Global Universal CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Universal CAR-T Cell Therapy Market Share by Region (2026-2031)
 Table 11. Universal CAR-T Cell Therapy Market Trends
 Table 12. Universal CAR-T Cell Therapy Market Drivers
 Table 13. Universal CAR-T Cell Therapy Market Challenges
 Table 14. Universal CAR-T Cell Therapy Market Restraints
 Table 15. Global Universal CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Universal CAR-T Cell Therapy Market Share by Players (2020-2025)
 Table 17. Global Top Universal CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Universal CAR-T Cell Therapy as of 2024)
 Table 18. Ranking of Global Top Universal CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Universal CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Universal CAR-T Cell Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Universal CAR-T Cell Therapy, Product and Application
 Table 22. Global Key Players of Universal CAR-T Cell Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Universal CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Universal CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 26. Global Universal CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Universal CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 28. Global Universal CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Universal CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 30. Global Universal CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Universal CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 32. North America Universal CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Universal CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Universal CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Universal CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Universal CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Universal CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Universal CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Universal CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Universal CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Universal CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Universal CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Cellectis Company Details
 Table 48. Cellectis Business Overview
 Table 49. Cellectis Universal CAR-T Cell Therapy Product
 Table 50. Cellectis Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 51. Cellectis Recent Development
 Table 52. Allogene Company Details
 Table 53. Allogene Business Overview
 Table 54. Allogene Universal CAR-T Cell Therapy Product
 Table 55. Allogene Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 56. Allogene Recent Development
 Table 57. Caribou Company Details
 Table 58. Caribou Business Overview
 Table 59. Caribou Universal CAR-T Cell Therapy Product
 Table 60. Caribou Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 61. Caribou Recent Development
 Table 62. Poseida Therapeutics Company Details
 Table 63. Poseida Therapeutics Business Overview
 Table 64. Poseida Therapeutics Universal CAR-T Cell Therapy Product
 Table 65. Poseida Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 66. Poseida Therapeutics Recent Development
 Table 67. Bangyao Biotechnology Company Details
 Table 68. Bangyao Biotechnology Business Overview
 Table 69. Bangyao Biotechnology Universal CAR-T Cell Therapy Product
 Table 70. Bangyao Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 71. Bangyao Biotechnology Recent Development
 Table 72. Usano Company Details
 Table 73. Usano Business Overview
 Table 74. Usano Universal CAR-T Cell Therapy Product
 Table 75. Usano Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 76. Usano Recent Development
 Table 77. Keji Pharmaceutical Company Details
 Table 78. Keji Pharmaceutical Business Overview
 Table 79. Keji Pharmaceutical Universal CAR-T Cell Therapy Product
 Table 80. Keji Pharmaceutical Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 81. Keji Pharmaceutical Recent Development
 Table 82. Beiheng Biotechnology Company Details
 Table 83. Beiheng Biotechnology Business Overview
 Table 84. Beiheng Biotechnology Universal CAR-T Cell Therapy Product
 Table 85. Beiheng Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 86. Beiheng Biotechnology Recent Development
 Table 87. Grace Biotechnology Company Details
 Table 88. Grace Biotechnology Business Overview
 Table 89. Grace Biotechnology Universal CAR-T Cell Therapy Product
 Table 90. Grace Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 91. Grace Biotechnology Recent Development
 Table 92. Celyad Company Details
 Table 93. Celyad Business Overview
 Table 94. Celyad Universal CAR-T Cell Therapy Product
 Table 95. Celyad Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 96. Celyad Recent Development
 Table 97. CRISPR Therapeutics Company Details
 Table 98. CRISPR Therapeutics Business Overview
 Table 99. CRISPR Therapeutics Universal CAR-T Cell Therapy Product
 Table 100. CRISPR Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 101. CRISPR Therapeutics Recent Development
 Table 102. Precision BioSciences Company Details
 Table 103. Precision BioSciences Business Overview
 Table 104. Precision BioSciences Universal CAR-T Cell Therapy Product
 Table 105. Precision BioSciences Revenue in Universal CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
 Table 106. Precision BioSciences Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Universal CAR-T Cell Therapy Picture
 Figure 2. Global Universal CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Universal CAR-T Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. First Generation CARs Features
 Figure 5. Second Generation CARs Features
 Figure 6. Third Generation CARs Features
 Figure 7. Global Universal CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Universal CAR-T Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 9. Hematoma Case Studies
 Figure 10. Solid Tumor Case Studies
 Figure 11. Universal CAR-T Cell Therapy Report Years Considered
 Figure 12. Global Universal CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Universal CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Universal CAR-T Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 15. Global Universal CAR-T Cell Therapy Market Share by Players in 2024
 Figure 16. Global Top Universal CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Universal CAR-T Cell Therapy as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Universal CAR-T Cell Therapy Revenue in 2024
 Figure 18. North America Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Universal CAR-T Cell Therapy Market Share by Country (2020-2031)
 Figure 20. United States Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Universal CAR-T Cell Therapy Market Share by Country (2020-2031)
 Figure 24. Germany Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Universal CAR-T Cell Therapy Market Share by Region (2020-2031)
 Figure 32. China Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Universal CAR-T Cell Therapy Market Share by Country (2020-2031)
 Figure 40. Mexico Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Universal CAR-T Cell Therapy Market Share by Country (2020-2031)
 Figure 44. Turkey Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Universal CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Cellectis Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 48. Allogene Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 49. Caribou Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 50. Poseida Therapeutics Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 51. Bangyao Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 52. Usano Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 53. Keji Pharmaceutical Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 54. Beiheng Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 55. Grace Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 56. Celyad Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 57. CRISPR Therapeutics Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 58. Precision BioSciences Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Buoyancy Activated Cell Sorting (BACS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11N16957
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Virtual Second Opinion Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26A16410
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Universal CAR-T Cell Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z16381
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Virus Removal Filter System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7E16937
Thu Sep 25 00:00:00 UTC 2025

Add to Cart